Skip to main content
Log in

Differentiation of small arterial enhancing hepatocellular carcinoma from non-tumorous arterioportal shunt with an emphasis on the precontrast CT scan

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the value of precontrast phase (PP) of quadriphasic CT for differentiation of small arterial enhancing hepatocellular carcinoma (HCC) from non-tumorous arterioportal (AP) shunt in patients with chronic liver disease.

Methods

Forty-eight patients with 28 HCCs and 28 AP shunts were enrolled. All lesions (5–20 mm) showed arterial hyperenhancement with isoattenuation on portal venous phase or delayed phase without typical features of AP shunt. We evaluated and analyzed the attenuation of the lesions with qualitative and quantitative methods in each phase. The size, location, shape, margin, and coexistent HCC were evaluated. Diagnostic performances were also compared with triphasic CT and quadriphasic CT including PP in prediction of AP shunts from HCCs.

Results

The round or oval shape and visually low attenuation on PP were independent predictors for differentiating HCCs from AP shunts in multivariate analysis. Our study also revealed significantly increased diagnostic performances for both observers when PP was added to the triphasic CT.

Conclusions

PP can be helpful in differentiation of small arterial enhancing HCCs from AP shunts. Careful evaluation of PP may lower need for follow-up CT or MRI, and can possibly achieve earlier diagnosis of small HCCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the bclc update and future prospects. Semin Liver Dis 30(1):61–74

    Article  CAS  PubMed  Google Scholar 

  2. McEvoy SH, McCarthy CJ, Lavelle LP, et al. (2013) Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the american association for the study of liver diseases. Radiographics 33(6):1653–1668

    Article  PubMed  Google Scholar 

  3. Lee JH, Lee JM, Kim SJ, et al. (2012) Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row ct: comparison with pathological differentiation. Br J Radiol 85(1017):e573–e583

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced us: comparison with histologic differentiation. Radiology 244(3):898–906

    Article  PubMed  Google Scholar 

  5. Park MJ, Kim YS, Lee WJ, et al. (2010) Outcomes of follow-up ct for small (5-10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population. Eur Radiol 20(10):2397–2404

    Article  PubMed  Google Scholar 

  6. Quaia E, Pizzolato R, De Paoli L, et al. (2013) Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced mr imaging. J Magn Reson Imaging 37(4):892–902

    Article  PubMed  Google Scholar 

  7. Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ (2008) Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 32(1):39–45

    Article  PubMed  Google Scholar 

  8. O’Malley ME, Takayama Y, Sherman M (2005) Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver ct in patients with cirrhosis or chronic liver disease. Am J Gastroenterol 100(7):1523–1528

    Article  PubMed  Google Scholar 

  9. Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Okusaka T (2006) Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein. J Gastroenterol Hepatol 21(1 Pt 2):288–294

    Article  CAS  PubMed  Google Scholar 

  10. Iannaccone R, Laghi A, Catalano C, et al. (2005) Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical ct in patients with cirrhosis. Radiology 234(2):460–467

    Article  PubMed  Google Scholar 

  11. Kim HC, Kim AY, Han JK, et al. (2002) Hepatic arterial and portal venous phase helical ct in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology 225(3):773–780

    Article  PubMed  Google Scholar 

  12. Doyle DJ, O’Malley ME, Jang HJ, Jhaveri K (2007) Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr 31(1):86–92

    Article  PubMed  Google Scholar 

  13. Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr (1996) Detecting hepatocellular carcinoma: value of unenhanced or arterial phase ct imaging or both used in conjunction with conventional portal venous phase contrast-enhanced ct imaging. AJR Am J Roentgenol 167(1):71–77

    Article  PubMed  Google Scholar 

  14. Ahn JH, Yu JS, Hwang SH, et al. (2010) Nontumorous arterioportal shunts in the liver: Ct and mri findings considering mechanisms and fate. Eur Radiol 20(2):385–394

    Article  PubMed  Google Scholar 

  15. Choi BI, Lee KH, Han JK, Lee JM (2002) Hepatic arterioportal shunts: dynamic ct and mr features. Korean J Radiol 3(1):1–15

    Article  PubMed Central  PubMed  Google Scholar 

  16. Huppertz A, Haraida S, Kraus A, et al. (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced mr imaging: correlation with histopathologic findings and spiral ct–initial observations. Radiology 234(2):468–478

    Article  PubMed  Google Scholar 

  17. Kim SH, Kim SH, Lee J, et al. (2009) Gadoxetic acid-enhanced mri versus triple-phase mdct for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675–1681

    Article  PubMed  Google Scholar 

  18. Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70(4):213–220

    Article  CAS  PubMed  Google Scholar 

  19. Takayasu K, Furukawa H, Wakao F, et al. (1995) Ct diagnosis of early hepatocellular carcinoma: sensitivity, findings, and ct-pathologic correlation. AJR Am J Roentgenol 164(4):885–890

    Article  CAS  PubMed  Google Scholar 

  20. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS (2000) Nontumorous hepatic arterial-portal venous shunts: Mr imaging findings. Radiology 217(3):750–756

    Article  CAS  PubMed  Google Scholar 

  21. Yoon SH, Lee JM, So YH, et al. (2009) Multiphasic mdct enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 193(6):W482–W489

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyun Jeong Park.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chung, B.M., Park, H.J., Park, S.B. et al. Differentiation of small arterial enhancing hepatocellular carcinoma from non-tumorous arterioportal shunt with an emphasis on the precontrast CT scan. Abdom Imaging 40, 2200–2209 (2015). https://doi.org/10.1007/s00261-015-0439-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-015-0439-3

Keywords

Navigation